Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.150
+0.050 (4.55%)
Nov 21, 2024, 1:20 PM EST - Market open
Coherus BioSciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -0.45 | -237.89 | -291.75 | -287.1 | 132.24 | 89.83 | Upgrade
|
| Depreciation & Amortization | 5.31 | 3.79 | 3.7 | 3.45 | 2.89 | 3.26 | Upgrade
|
| Other Amortization | 2.41 | 2.41 | 6.43 | 4.26 | 3.48 | 2.34 | Upgrade
|
| Loss (Gain) From Sale of Assets | -176.65 | - | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 10.57 | - | - | 3.21 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.05 | -3.05 | -0.73 | 1.1 | - | -0.17 | Upgrade
|
| Stock-Based Compensation | 32.22 | 43.11 | 50.74 | 51.36 | 38.16 | 33.59 | Upgrade
|
| Other Operating Activities | 59.94 | 53.58 | 69.75 | 143.93 | 12.02 | 13.82 | Upgrade
|
| Change in Accounts Receivable | 48.97 | -150.68 | 13.05 | 34.06 | -15.22 | -141.99 | Upgrade
|
| Change in Inventory | -37.29 | -46.73 | -47.35 | -6.25 | -38.36 | -48.58 | Upgrade
|
| Change in Accounts Payable | -11.07 | 23.76 | -4.55 | 0.87 | -9.82 | 9.89 | Upgrade
|
| Change in Other Net Operating Assets | 7.12 | 136.83 | -40.41 | 13.68 | 28.75 | 66.36 | Upgrade
|
| Operating Cash Flow | -61.99 | -174.88 | -241.12 | -37.43 | 154.15 | 28.36 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 443.63% | - | Upgrade
|
| Capital Expenditures | -0.29 | -0.29 | -2.04 | -1.29 | -7.23 | -1.82 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.85 | 0.85 | - | - | 0.18 | - | Upgrade
|
| Cash Acquisitions | - | 7 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1.05 | -1.05 | -2.43 | - | -7.5 | -11.08 | Upgrade
|
| Investment in Securities | 51.1 | 138.14 | -127.38 | -1.12 | 0.16 | 0.17 | Upgrade
|
| Other Investing Activities | -12.37 | - | -35 | -136 | - | - | Upgrade
|
| Investing Cash Flow | 266.07 | 144.64 | -166.85 | -138.41 | -14.4 | -12.73 | Upgrade
|
| Long-Term Debt Issued | - | - | 240.68 | - | 222.16 | 72.96 | Upgrade
|
| Total Debt Issued | 36.98 | - | 240.68 | - | 222.16 | 72.96 | Upgrade
|
| Long-Term Debt Repaid | - | - | -190.75 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -223.41 | - | 49.93 | - | 222.16 | 72.96 | Upgrade
|
| Issuance of Common Stock | 3.32 | 74.22 | 9.37 | 54.3 | 21.23 | 17.23 | Upgrade
|
| Repurchase of Common Stock | -2.79 | -3.59 | -3.74 | -1.75 | -0.88 | -0.82 | Upgrade
|
| Other Financing Activities | 36.04 | -1.03 | -1.23 | -0.67 | -18.56 | - | Upgrade
|
| Financing Cash Flow | -186.84 | 69.6 | 54.33 | 51.88 | 223.95 | 89.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.28 | Upgrade
|
| Net Cash Flow | 17.24 | 39.36 | -353.65 | -123.96 | 363.69 | 104.72 | Upgrade
|
| Free Cash Flow | -62.27 | -175.17 | -243.16 | -38.72 | 146.91 | 26.53 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 453.70% | - | Upgrade
|
| Free Cash Flow Margin | -20.46% | -68.09% | -115.22% | -11.86% | 30.88% | 7.45% | Upgrade
|
| Free Cash Flow Per Share | -0.55 | -1.86 | -3.13 | -0.51 | 1.76 | 0.36 | Upgrade
|
| Cash Interest Paid | 37.86 | 37.86 | 34.88 | 18.68 | 16.96 | 15.26 | Upgrade
|
| Cash Income Tax Paid | - | -0.12 | 0.04 | 1.22 | 3.95 | 1.73 | Upgrade
|
| Levered Free Cash Flow | 42.63 | -71.2 | -156.33 | -60.97 | 83.04 | 8.89 | Upgrade
|
| Unlevered Free Cash Flow | 60.49 | -48.27 | -142.47 | -50.88 | 92.78 | 17.56 | Upgrade
|
| Change in Net Working Capital | -100.7 | -26.92 | 31.88 | -60.51 | 31.23 | 73.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.